The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation
暂无分享,去创建一个
J. Lieberman | C. Gong | E. Song | Hai Hu | Xiao Zhen Zhou | K. Lu | Pengyu Huang | Man-Li Luo | Yandan Yao | G. Wulf | M. Zheng | Shuo Wei | Chun-Hau Chen | X. Zhou
[1] T. Hunter,et al. Prolyl isomerase Pin1 in cancer , 2014, Cell Research.
[2] J. Lieberman,et al. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. , 2014, Cancer research.
[3] S. Bicciato,et al. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast , 2013, EMBO molecular medicine.
[4] J. Goldenring. A central role for vesicle trafficking in epithelial neoplasia: intracellular highways to carcinogenesis , 2013, Nature Reviews Cancer.
[5] James Lee,et al. Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells , 2013, Journal of Cell Science.
[6] H. Shih,et al. SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function. , 2013, Cancer research.
[7] Gabriela Kalna,et al. ROS Production and NF-κB Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer Initiation , 2013, Cell stem cell.
[8] S. Lok,et al. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. , 2012, Cancer research.
[9] E. Canaani,et al. TrxG and PcG Proteins but Not Methylated Histones Remain Associated with DNA through Replication , 2012, Cell.
[10] R. Roskoski. ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.
[11] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[12] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[13] Stephen J. Elledge,et al. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop , 2012, Nature Medicine.
[14] L. Nicholson,et al. Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease , 2012, Cell.
[15] C. Perou,et al. Defining the cellular precursors to human breast cancer , 2011, Proceedings of the National Academy of Sciences.
[16] Min-Jung Kim,et al. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem‐like cells , 2011, FEBS letters.
[17] M. Sabel,et al. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development , 2011, Modern Pathology.
[18] A. Goate,et al. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. , 2011, Molecular cell.
[19] Yi Zheng,et al. Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity , 2011, PloS one.
[20] W. Woodward,et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. , 2011, Cancer cell.
[21] A. Huang,et al. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization , 2011, BMC Cancer.
[22] J. Blenis,et al. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. , 2010, Molecular cell.
[23] T. Yeatman,et al. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. , 2010, The Journal of clinical investigation.
[24] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[25] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[26] P. Fortina,et al. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo , 2009, Proceedings of the National Academy of Sciences.
[27] M. Wicha. Targeting breast cancer stem cells. , 2009, Breast.
[28] H. Stenmark. Rab GTPases as coordinators of vesicle traffic , 2009, Nature Reviews Molecular Cell Biology.
[29] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] H. Kölbl,et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. , 2008, Cancer research.
[31] Siew Hong Leong,et al. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. , 2008, Cancer research.
[32] Daniel Medina,et al. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. , 2008, Cancer research.
[33] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[34] J. Lieberman,et al. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.
[35] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[36] Xiao Zhen Zhou,et al. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease , 2007, Nature Reviews Molecular Cell Biology.
[37] Suzanne Schubbert,et al. Hyperactive Ras in developmental disorders and cancer , 2007, Nature Reviews Cancer.
[38] T. Barrette,et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.
[39] Q. Zhan,et al. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. , 2006, Cancer research.
[40] Haiyan I. Li,et al. Purification and unique properties of mammary epithelial stem cells , 2006, Nature.
[41] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[42] J. Gutkind,et al. Regulation of the Transcriptional Activity of c-Fos by ERK , 2005, Journal of Biological Chemistry.
[43] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[44] G. Dontu,et al. Survival of Mammary Stem Cells in Suspension Culture: Implications for Stem Cell Biology and Neoplasia , 2005, Journal of Mammary Gland Biology and Neoplasia.
[45] G. Mills,et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers , 2004, Nature Medicine.
[46] B. Dynlacht,et al. A novel mechanism for mitogen-activated protein kinase localization. , 2004, Molecular biology of the cell.
[47] R. Dickinson,et al. Both Nuclear-Cytoplasmic Shuttling of the Dual Specificity Phosphatase MKP-3 and Its Ability to Anchor MAP Kinase in the Cytoplasm Are Mediated by a Conserved Nuclear Export Signal* , 2004, Journal of Biological Chemistry.
[48] W. Mobley,et al. NGF Signaling in Sensory Neurons Evidence that Early Endosomes Carry NGF Retrograde Signals , 2003, Neuron.
[49] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[50] William C Hahn,et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. , 2003, RNA.
[51] Lee Bardwell,et al. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. , 2003, The Biochemical journal.
[52] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[53] Sam W. Lee,et al. PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells , 2002, Molecular and Cellular Biology.
[54] J. B. Sajous,et al. Ras signalling on the endoplasmic reticulum and the Golgi , 2002, Nature Cell Biology.
[55] M. Callanan,et al. Graphical Representation of a Generalized Linear Model-Based Statistical Test Estimating the Fit of the Single-Hit Poisson Model to Limiting Dilution Assays , 2001, The Journal of Immunology.
[56] K. Anderson,et al. Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway , 2001, Nature.
[57] Tianhua Niu,et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1 , 2001, The EMBO journal.
[58] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[59] W. Hahn,et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.
[60] Masafumi Nakamura,et al. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC , 2001, Nature Cell Biology.
[61] H. Andersson,et al. ERGIC-53 and traffic in the secretory pathway. , 2000, Journal of cell science.
[62] E. Nishida,et al. A conserved docking motif in MAP kinases common to substrates, activators and regulators , 2000, Nature Cell Biology.
[63] M. Kirschner,et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. , 1997, Science.
[64] W. Balch,et al. Rab2 Is Essential for the Maturation of Pre-Golgi Intermediates* , 1996, The Journal of Biological Chemistry.
[65] T. Hunter,et al. A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.